An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
At the intersection of breast cancer and heart failure
At the intersection of breast cancer and heart failure
Protecting the hearts of cancer survivors
Our groundbreaking work in an emerging, sensitive area